Infection prevention
l Net saving of £107,530 per 1,000 patients (literature-based)
l This equates to £1.49–£2.38 saved for every £1 spent
Cardiac surgery (highest savings): l Up to £228,090 saved per 1,000 patients l Equivalent to £3.92 saved for every £1 spent l Saving £874 per patient
Hip and knee replacements: l £84,430–£86,650 saved per 1,000 patients l Equivalent to £2.10 saved for every £1 spent
Mr Simon Jones MBChB, MSc, FRCS (Tr&Orth), Consultant Trauma and Orthopaedic Surgeon and Clinical Lead for Elective Surgery at MYT, commented, “We have seen incredible results from the use of Steriwave, significantly reducing infections that can cause so much harm to patients. This protocol represents a major advance in patient safety and demonstrates what can be achieved with innovative thinking and collaboration.” Furthermore, modelling indicates that the
technology: l Averts 9.8 SSIs for every 1,000 hip and knee patients treated
l Generates an average saving of £108 per patient across major surgeries
Extrapolated nationally across estimated surgical volumes, photodisinfection could save UK hospitals – including the NHS – up to £200 million annually. Although ongoing data collection will refine these estimates, early results suggest that photodisinfection technology may represent a highly cost- effective enhancement to pre-operative care. Internationally, MYT’s data has contributed
to the technology’s deployment across Canada. A real-world, peer-reviewed study conducted at Vancouver General Hospital, published in the Canadian Journal of Surgery, evaluated more than 13,000 adult spine surgery patients over eight years. Its conclusion was unequivocal: nasal photodisinfection should be the standard of care for all patients undergoing elective or emergent spine surgeries. Ultimately, innovative, non-antibiotic
technologies could play a vital role in safeguarding patient safety and reducing healthcare-associated infections in a world where antimicrobial resistance continues to rise. From a 71% reduction in SSIs, to high patient and nurse satisfaction, and compelling economic savings, the early data paint a persuasive picture of a technology that is easy to use, well-tolerated, and potentially transformative.
Say goodbye to pre-wetted wipes and improve sustainability with JET LUX.
MIN 1
MADE IN THE UK
SPORICIDAL IN
1 MINUTE
EFFECTIVE AGAINST BIOFILMS
Product Code: CCH010701 - NHSSC: FAL24119
LOW ODOUR LIGHT TOUCH
EFFECTIVE WITH ANY WIPE
About the author
Jason Hickok is the Vice President, Clinical and Medical Affairs at Ondine Biomedical. Jason joined Ondine after fifteen years with HCA Healthcare, where he served as Assistant Vice President for Research and Patient Safety in the Clinical Services Group (CSG). Under his stewardship, HCA established CSG’s Infection Prevention Department, successfully deployed multiple quality improvement toolkits, and conducted a large scale public/private research study in partnership with Centers for Disease Control and Prevention, Harvard Pilgrim Health Care Institute, and the Agency for Healthcare Research and Quality.
JET LUX
TM
Scan to request your free evaluation
Copyright © Tristel Solutions Limited - Mkt-Adv-3361 - 11/NOV/2025 - V1 CSJ January 2026 I
www.clinicalservicesjournal.com 43
A
E
P
V
P
O
R
R
O
P
V
P
E
D
-
-
A
P
P
O
R
V
E
D
A
D
-
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
